- Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circulation research. 2002 Academic Article GET IT
- Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998 Academic Article GET IT
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
Times cited: 307